FGHQF
Price
$0.15
Change
+$0.05 (+50.00%)
Updated
Jul 31 closing price
Capitalization
372.86M
SKYE
Price
$3.54
Change
+$0.25 (+7.60%)
Updated
Aug 25, 04:59 PM (EDT)
Capitalization
109.7M
Interact to see
Advertisement

FGHQF vs SKYE

Header iconFGHQF vs SKYE Comparison
Open Charts FGHQF vs SKYEBanner chart's image
Frontage
Price$0.15
Change+$0.05 (+50.00%)
Volume$130
Capitalization372.86M
Skye Bioscience
Price$3.54
Change+$0.25 (+7.60%)
Volume$4.87K
Capitalization109.7M
FGHQF vs SKYE Comparison Chart in %
Loading...
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGHQF vs. SKYE commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGHQF is a Buy and SKYE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (FGHQF: $0.15 vs. SKYE: $3.29)
Brand notoriety: FGHQF and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGHQF: 0% vs. SKYE: 42%
Market capitalization -- FGHQF: $372.86M vs. SKYE: $109.7M
FGHQF [@Biotechnology] is valued at $372.86M. SKYE’s [@Biotechnology] market capitalization is $109.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.72B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGHQF’s FA Score shows that 1 FA rating(s) are green whileSKYE’s FA Score has 0 green FA rating(s).

  • FGHQF’s FA Score: 1 green, 4 red.
  • SKYE’s FA Score: 0 green, 5 red.
According to our system of comparison, FGHQF is a better buy in the long-term than SKYE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGHQF’s TA Score shows that 0 TA indicator(s) are bullish while SKYE’s TA Score has 4 bullish TA indicator(s).

  • FGHQF’s TA Score: 0 bullish, 1 bearish.
  • SKYE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FGHQF is a better buy in the short-term than SKYE.

Price Growth

FGHQF (@Biotechnology) experienced а 0.00% price change this week, while SKYE (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was +18.77%, and the average quarterly price growth was +29.32%.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FGHQF($373M) has a higher market cap than SKYE($110M). FGHQF has higher P/E ratio than SKYE: FGHQF (374.50) vs SKYE (3.57). FGHQF YTD gains are higher at: 48.317 vs. SKYE (16.254).
FGHQFSKYEFGHQF / SKYE
Capitalization373M110M339%
EBITDAN/A-41.68M-
Gain YTD48.31716.254297%
P/E Ratio374.503.5710,502%
RevenueN/A0-
Total CashN/A48.6M-
Total DebtN/A368K-
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FGHQFSKYE
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
89%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
20%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
3%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
4%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
76%
Aroon
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FGHQF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HUMEX16.830.50
+3.06%
Huber Mid Cap Value Instl
MUSBX36.770.55
+1.52%
MFS Blended Research Core Equity B
PRERX27.890.39
+1.42%
Principal Real Estate Securities R3
PPYIX9.350.13
+1.41%
PIMCO RAE International Instl
WFEAX15.230.21
+1.40%
Allspring International Equity A

FGHQF and

Correlation & Price change

A.I.dvisor tells us that FGHQF and ANL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FGHQF and ANL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGHQF
1D Price
Change %
FGHQF100%
N/A
ANL - FGHQF
25%
Poorly correlated
-0.86%
SKYE - FGHQF
15%
Poorly correlated
-7.32%
LEXX - FGHQF
9%
Poorly correlated
+0.88%
HMTXF - FGHQF
8%
Poorly correlated
+3.36%
ZVRA - FGHQF
4%
Poorly correlated
-0.74%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
-7.32%
CRBP - SKYE
48%
Loosely correlated
+0.93%
JANX - SKYE
40%
Loosely correlated
+1.25%
VKTX - SKYE
34%
Loosely correlated
+1.33%
ABOS - SKYE
32%
Poorly correlated
+12.50%
NKTR - SKYE
31%
Poorly correlated
-3.46%
More